default author photo

Peter Tapley

University of Queensland - TetraQ

St Lucia

Brisbane, Queensland 4072

Australia

SCHOLARLY PAPERS

2

DOWNLOADS

471

TOTAL CITATIONS

4

Scholarly Papers (2)

1.

First Report of a Phase 1 Randomised Trial of Molecular Clamp-Stabilised Spike Protein-Based and MF59-Adjuvanted Vaccine for SARS-CoV-2

Number of pages: 37 Posted: 01 Feb 2021
University of Queensland - School of Chemistry and Molecular Biosciences, University of Melbourne - Department of Microbiology and Immunology (DMI), Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Queensland - School of Chemistry and Molecular Biosciences, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland, University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), Tanawell Consulting, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Queensland - TetraQ, University of Queensland - TetraQ, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, Burnet Institute, Burnet Institute, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Queensland - Institute for Molecular Bioscience, University of Queensland - School of Chemistry and Molecular Biosciences and University of Queensland - School of Chemistry and Molecular Biosciences
Downloads 414 (176,035)
Citation 2

Abstract:

Loading...

2.

Rapid Application of the Molecular Clamp Platform for SARS-CoV-2

Number of pages: 65 Posted: 24 Nov 2020
University of Queensland - Institute for Molecular Bioscience, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Melbourne - Department of Microbiology and Immunology (DMI), Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, Viroclinics Xplore, Viroclinics Xplore, Viroclinics Xplore, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, University of Queensland - TetraQ, StageBio, University of Queensland - Centre for Advanced Materials Processing and Manufacturing, University of Queensland - TetraQ, University of Queensland - TetraQ, University of Melbourne - Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity - WHO Collaborating Centre for Reference and Research on Influenza, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - Australian Infectious Diseases Research Centre, Utrecht University - Division of Pathology, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences and University of Queensland - School of Chemistry and Molecular Biosciences
Downloads 57 (989,921)
Citation 2

Abstract:

Loading...

SARS-CoV-2, Molecular Clamp, subunit vaccine, rapid response, hamster protection, neutralising antibodies, polyfunctional T cells, cytotoxic CD8+ T cells, helper T cells, immune breadth